Human Trial Of 'Covaxin' Begins At SUM Hospital In Bhubaneswar

Vaccination was performed after volunteers underwent a screening process (Representational)


The human trial of India’s first indigenous vaccine candidate “Covaxin” started on the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Monday.

Covaxin, the vaccine developed by Bharat Biotech, has been administered to a number of individuals, who volunteered to be a part of the trial, mentioned Dr E Venkat Rao, Principal Investigator of the trial course of.

The vaccination was performed after the volunteers underwent a rigorous screening process.

“There was plenty of enthusiasm amongst individuals who provided themselves to be volunteers for the trial,” he mentioned.

The Indian Council for Medical Analysis (ICMR) which is collaborating with Bharat Biotech for the event of the vaccine, has chosen 12 medical institutes throughout the nation. IMS and SUM Hospital is the one such institute in Odisha to be chosen for the aim.

These to volunteer for the challenge could contact the institute by registering on-line at beneath the part register for scientific trials.

Nevertheless, volunteers are required to be disease-free and may display themselves by a easy questionnaire accessible on the identical web site, an announcement from SUM hospital mentioned.

(This story has not been edited by NDTV workers and is auto-generated from a syndicated feed.)


Please enter your comment!
Please enter your name here